112 related articles for article (PubMed ID: 28248432)
1. Neoadjuvant chemotherapy in geriatric head and neck cancers.
Patil VM; Noronha V; Joshi A; Ramaswamy A; Dhumal S; Juvekar S; Arya S; Mahajan A; Chaturvedi P; D'Cruz A; Bhattacharjee A; Prabhash K
Head Neck; 2017 May; 39(5):886-892. PubMed ID: 28248432
[TBL] [Abstract][Full Text] [Related]
2. Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.
Patil VM; Noronha V; Joshi A; Muddu VK; Dhumal S; Arya S; Juvekar S; Pai P; Chatturvedi P; Devendra AC; Ghosh S; D'cruz A; Kumar P
Indian J Cancer; 2014; 51(1):20-4. PubMed ID: 24947091
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.
Patil VM; Prabhash K; Noronha V; Joshi A; Muddu V; Dhumal S; Arya S; Juvekar S; Chaturvedi P; Chaukar D; Pai P; Kane S; Patil A; Agarwal JP; Ghosh-Lashkar S; Dcruz A
Oral Oncol; 2014 Oct; 50(10):1000-4. PubMed ID: 25130412
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
Boon E; van der Graaf WT; Gelderblom H; Tesselaar ME; van Es RJ; Oosting SF; de Bree R; van Meerten E; Hoeben A; Smeele LE; Willems SM; Witjes MJ; Buter J; Baatenburg de Jong RJ; Flucke UE; Peer PG; Bovée JV; Van Herpen CM
Head Neck; 2017 Jan; 39(1):140-146. PubMed ID: 27507299
[TBL] [Abstract][Full Text] [Related]
8. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach.
Sadeghi N; Li NW; Taheri MR; Easley S; Siegel RS
Head Neck; 2016 Dec; 38(12):1837-1846. PubMed ID: 27299983
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck.
Hainsworth JD; Spigel DR; Burris HA; Markus TM; Shipley D; Kuzur M; Lunin S; Greco FA
Cancer; 2009 May; 115(10):2138-46. PubMed ID: 19288572
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
12. Planned post-chemoradiation neck dissection: significance of radiation dose.
Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
Vokes EE; Moran WJ; Mick R; Weichselbaum RR; Panje WR
J Clin Oncol; 1989 Jul; 7(7):838-45. PubMed ID: 2661732
[TBL] [Abstract][Full Text] [Related]
14. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
15. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
Ock CY; Keam B; Lim Y; Kim TM; Lee SH; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
Head Neck; 2016 Feb; 38(2):277-84. PubMed ID: 26104823
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
[TBL] [Abstract][Full Text] [Related]
17. IMRT-SIB with concurrent and neo-adjuvant platinum-based chemotherapy for locally advanced head and neck squamous cell cancer: analysis of clinical outcomes in a retrospective series of a single institution.
Mazzeo E; Antognoni P; Parmiggiani M; D'Ambrosio C; De Marco G; Marra L; Gottardi G; Bertoni F
Tumori; 2014; 100(6):652-9. PubMed ID: 25688499
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in head and neck Ewing sarcoma family of tumors.
Biswas B; Thakar A; Mohanti BK; Vishnubhatla S; Bakhshi S
Laryngoscope; 2015 Mar; 125(3):E112-7. PubMed ID: 25345585
[TBL] [Abstract][Full Text] [Related]
19. Retrospective review of patients with locally advanced esophageal cancer treated at the University of Pittsburgh.
Defoe SG; Pennathur A; Flickinger JC; Heron DE; Gibson MK; Luketich JD; Greenberger JS
Am J Clin Oncol; 2011 Dec; 34(6):587-92. PubMed ID: 22101387
[TBL] [Abstract][Full Text] [Related]
20. Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer.
Sylvie L; Silvia S; Salah-Eddin AB; Markus F; Florian L; Peter TP; Bernhard H; Martin A; Alexander N
Eur J Cancer; 2015 Sep; 51(14):1918-26. PubMed ID: 26216588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
